ECLIPSE DENTAL LABORATORY LIMITEDActive
Key figures
ECLIPSE DENTAL LABORATORY LIMITED does not disclose its turnover in its latest accounts; the profit for the year is as stated in the accounts.
Ratios
2025/26Balance sheet structure
Dividends
from the accountsDividends paid in the financial year: £13,750.
Filed accounts2020/21–2025/26
| 2021/22 | 2022/23 | 2023/24 | 2024/25 | 2025/26 | |
|---|---|---|---|---|---|
| Profit for the year | 881 | 10,766 | 51,162 | 11,559 | 566 |
| Cash at bank and in hand | 12,014 | 1,423 | 4,067 | 2,115 | 488 |
| Total assets | 69,967 | 61,185 | 86,288 | 64,637 | 54,355 |
| Total liabilities | 75,675 | 82,220 | 68,496 | — | 61,758 |
| Net assets / total equity | 6,383 | 349 | 36,911 | 25,620 | 12,436 |
| Average number of employees | 5 | 5 | 5 | 7 | 0 |
| Dividends paid | 14,411 | 16,800 | 14,600 | 22,850 | 13,750 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Summary: ECLIPSE DENTAL LABORATORY LIMITED
Company
ECLIPSE DENTAL LABORATORY LIMITED is a private limited company registered with Companies House under company number SC338726. It was incorporated on 1 Mar 2008. Its status is active. The registered office is in Glasgow (G68). Its nature of business (SIC 2007) is other professional, scientific and technical activities n.e.c. (74909).
Accounts
The latest accounts in the database are for 2025/26 (period ending 31 Mar 2026); the company files small company accounts (filleted). Profit for the year was £566. Net assets were £12,436, down 51.5% on the previous year. Cash at bank and in hand was £488. Total assets were £54,355 and total liabilities £61,758. The company had an average of 0 employees. Figures are available for 6 financial years (2020/21–2025/26).
Control and charges
2 persons with significant control are registered.
Filing deadlines
The next accounts are due by 31 Dec 2027. The next confirmation statement is due by 15 Mar 2027.